Hattori Y, Inomata N
Laboratory of Molecular Pharmacology, Suntory Institute for Biomedical Research, Osaka, Japan.
Jpn J Pharmacol. 1992 Apr;58(4):365-73. doi: 10.1254/jjp.58.365.
Using a whole cell clamp technique, the blockade of sodium currents (INa) by pilsicainide, a new antiarrhythmic agent, applied either intracellularly or extracellularly, was studied in single myocytes isolated from guinea pig right ventricle. Pilsicainide applied extracellularly inhibited the peak amplitude of INa in concentration- (from 10(-5) M to 10(-4) M) and rate- (from 0.5 Hz to 3.0 Hz) dependent manners. The onset rate of the blockade in INa was almost constant, independent of frequency of stimulus, but higher at high concentration of pilsicainide. The time constant in the recovery phase from INa inactivation remained almost constant (65 to 75 msec) in the range of concentrations used. Similar results were obtained by intracellular application of 10(-3) M pilsicainide. Pilsicainide applied intracellularly inhibited INa in a rate-dependent manner. The blocking potency of internally applied pilsicainide almost corresponded to that of external 10(-5) M pilsicainide. The onset rate of INa inactivation (from 0.098/pulse to 0.130/pulse) and the recovery time constant (77 msec) was similar to those of external 10(-5) M pilsicainide. These results suggest that pilsicainide, irrespective of intra- or extracellular application, shares a common binding site to block INa in cardiac myocytes.
采用全细胞钳技术,在从豚鼠右心室分离的单个心肌细胞中,研究了新型抗心律失常药物吡西卡尼在细胞内或细胞外应用时对钠电流(INa)的阻断作用。细胞外应用吡西卡尼以浓度依赖性(从10^(-5) M至10^(-4) M)和频率依赖性(从0.5 Hz至3.0 Hz)的方式抑制INa的峰值幅度。INa阻断的起始速率几乎恒定,与刺激频率无关,但在高浓度吡西卡尼时更高。在所用浓度范围内,从INa失活恢复阶段的时间常数几乎保持恒定(65至75毫秒)。通过细胞内应用10^(-3) M吡西卡尼也获得了类似结果。细胞内应用吡西卡尼以频率依赖性方式抑制INa。细胞内应用吡西卡尼的阻断效力几乎与细胞外10^(-5) M吡西卡尼的阻断效力相当。INa失活的起始速率(从0.098/脉冲至0.130/脉冲)和恢复时间常数(77毫秒)与细胞外10^(-5) M吡西卡尼的相似。这些结果表明,无论细胞内还是细胞外应用,吡西卡尼都通过一个共同的结合位点来阻断心肌细胞中的INa。